Catalyst Pharmaceuticals Inc – Quartalsfinanzdaten (NASDAQ:CPRX) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit 70.88 M60.04 M71.3 M32.44 M44.89 M 208.67 M Mittelzufluss aus Investitionstätigkeit -88 K0-26 K0-32 K -58 K Zahlungsströme aus der Finanzierungstätigkeit 4.43 M3.06 M872 K4.65 M-25.58 M -16.99 M Freier Cashflow 70.79 M60.04 M71.27 M32.44 M44.86 M 208.61 M

Nachrichten

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up

CGON Stock Up 60.8% in Six Months: Here's What You Need to Know

Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now